C4 Therapeutics, Inc. · NASDAQ:CCCC

Wasatch Advisors LP's stake in C4 Therapeutics, Inc. fell to 4.70% (Schedule 13G/A)

Event Mar 31, 2026 · Filed Apr 22, 2026

Wasatch Advisors LP's stake in C4 Therapeutics, Inc. fell to 4.70%, 4,581,761 shares, as a passive investor on Mar 31, 2026. Filed Apr 22, 2026 (Schedule 13G/A).

Stake
4.70%
Shares
4,581,761
Intent
Passive
What changed
Fell below 5%

The filing in full

HolderStakeShares
Wasatch Advisors LP4.70%4,581,761

Source

View original at SEC

Related